Comment

Comment by Lorraine on January 9, 2012 at 9:29am

I've been thinking about this product and trying to imagine using it each night. I am mostly trying to justify the price tag. Although I have been away in hotel rooms and enjoyed the accessibility of having the receiver in my hand while I sleep to see at any time, I am having a hard time justifying the expense whether covered by insurance or not. I feel like this product may be over thought and over designed driving up the cost and thus making it unattainable for most potential users. Something much more simple and cheaper could be equally effective. The hard part for us is doing insertions and then being able to rely on the DexCom technology. Even when it says he's in range, I still do at least one finger stick per night to be certain that Dexie isn't taking a nap. Since I can't do that from this device, the price, for me, is just way out of proportion with the added benefit this product provides.

Comment by Biomuse on January 9, 2012 at 9:13am

The features of this are great in theory, especially for monitoring children with Type I, but the actual glucose sensor in the Medtronic Revel system leaves a whole lot to be desired. When Dexcom (which already has a pretty good range and a very bright light and loud alarm) adds smartphone capability to their excellent CGM, then I'll be interested in the concept.

Comment by Tom Goffe on January 4, 2012 at 7:34am

According to a Reuters online news story about the device, the expected price is around $3,000.00. Also in the story is a prediction from Medtronic that the low glucose suspend feature of the "Veo" system which is currently available in Europe should be available for sale in the United States in around 2 1/2 years -that is if the FDA grants approval once the current product tests are complete.. The story also reveals that Medtronic is also working on integrating the Revel Pump/CGMS system with smart phone technology.